Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New Wnt signaling inhibitors discovered in Germany

Oct. 28, 2011

Adventrx and FDA agree on pivotal ANX-514 trial

Oct. 28, 2011

S*BIO plans phase III program for pacritinib

Oct. 27, 2011

Solasia Pharma begins study of darinaparsin injection in Japan

Oct. 27, 2011

Immunovaccine clear to start phase I/II DPX-Survivac trial in Canada

Oct. 27, 2011

Avila Therapeutics describes new BTK inhibitor

Oct. 27, 2011

DelMar Pharmaceuticals commences phase I/II trial of VAL-083

Oct. 26, 2011

FDA grants IND clearance for phase II trial of Aeterna Zentaris' AEZS-108 in breast cancer

Oct. 26, 2011

Bayer's phase III CORRECT trial meets primary endpoint

Oct. 26, 2011

CDC advisory committee recommends Merck & Co.'s HPV vaccine for boys and young men

Oct. 26, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
BIO 2026: Alternatives to funding orphan drugs
BioWorld
At the BIO International Convention, nonprofit and for-profit companies discussed ways to fund orphan drug development, especially for ultra-rare diseases where...
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...